Evaluating the Risk of Cervical Precancer with a Combination of Cytologic, Virologic, and Visual Methods
- 1 November 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (11), 2665-2668
- https://doi.org/10.1158/1055-9965.epi-05-0151
Abstract
Several test modalities (cytologic, molecular, and visual) may be used for cervical cancer screening, triage, and follow-up. Although no currently available single test for cervical neoplasia can detect disease with both high sensitivity and specificity, combinations of available tests allow for improved risk prediction. We therefore evaluated the combination of liquid-based cytology (LBC), human papillomavirus (HPV) DNA testing, and visual inspection (cervicography), taken at a single point in time, to predict risk of subsequent cervical intraepithelial neoplasia 3 (CIN3) or cancer developing within 2 years in a triage population of 5,060 women referred for equivocal or mildly abnormal cytology. The concurrent administration of all three test modalities showed that combinations of these test modalities permitted clear and distinct risk stratification. Among HPV-positive women with high-grade LBC and high-grade cervicography results, 79.1 % [95% confidence interval (95% CI), 64.0- 90.0] were diagnosed with histologic CIN3 or cancer within 2 years, supporting a “see-and-treat” clinical application. Conversely, only 1.4% (95% CI, 0.7-2.5) of women with a negative HPV, normal cervigram, and second normal cytology result developed CIN3 or cancer. Because this low absolute risk was largely attributable to the negative HPV test, our results suggest a lack of benefit for a secondary or tertiary test result given an HPV-negative test result. Within HPV-positive women, however, we observed a steadily increasing absolute risk for cervical precancer/cancer with increasing numbers and severity of abnormal test results. We conclude that the clear discrimination of cervical cancer risk provided by multiple test modalities is consistent with our understanding of cervical etiology related to HPV natural history.Keywords
This publication has 12 references indexed in Scilit:
- Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or MoreObstetrics & Gynecology, 2004
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and CancerCA: A Cancer Journal for Clinicians, 2002
- Can cervicography be improved? An evaluation with arbitrated cervicography interpretationsAmerican Journal of Obstetrics and Gynecology, 2002
- 2001 Consensus Guidelines for the Management of Women With Cervical Cytological AbnormalitiesJAMA, 2002
- Estimates of the world‐wide prevalence of cancer for 25 sites in the adult populationInternational Journal of Cancer, 2001
- Cervicography for triage of women with mildly abnormal cervical cytology resultsAmerican Journal of Obstetrics and Gynecology, 2001
- Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized TrialJNCI Journal of the National Cancer Institute, 2001
- ASCUS-LSIL Triage StudyActa Cytologica, 2000